Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Dean J. Kereiakes

October 12, 2015

REGISTER for free or LOG IN to view this content

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presentation

TCT 2015

Up Next

Presentation TCT 2015

HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Trialist/Guideline Perspective

Presenter: John A. Bittl

October 12, 2015

More slides +

Presentation TCT 2015

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Presenter: John G. Webb

October 12, 2015

Presentation TCT 2015

Adenosine Variability and Other FFR Artifacts

Presenter: Morton J. Kern

October 12, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.